This is research, not a buy or sell recommendation. Robo-advice in Taiwan requires an FSC licence; FEAF analyses, explains and monitors, and the investor makes the decision. Judgement thresholds are working rules pending review by the team's finance members.
Plain-language summary of valuation, growth, profitability, balance sheet, and recent MOPS filings.
Mixed picture: 3 strengths against 2 watch-outs. Weigh them against your own goals.
Points to watch for a moderate profile: see the items marked above.
In plain words
For stock code 4755, revenue fell -9.2% in 2025 and -1.1% year on year in Q2 2026, reflecting weak profitability with a return on equity of 6.8% and a net margin of 9.6%. Conversely, the company maintains a light debt load with liabilities at 33.6% of total assets in Q2 2026 and generated positive free cash flow of 644 NT$ million in 2025. Its P/E of 20.77 is close to the Chemicals median of 18.46, though there are 3 verified alerts, including the latest on 2026-11-11 regarding endorsement and guarantee regulations. Ultimately, final investment decisions rest entirely in the hands of the investor.
Written by gemini-3.6-flash from the facts above; every number was checked against them.
Strengths
+The current price implies -0.4% perpetual growth, within the 3.5% ceiling: expectations look attainable. source (Valuation) →
+Liabilities are only 33.6% of total assets (Q2 2026): a light debt load. source (Financials) →